| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614581 | Journal of Cardiology | 2017 | 8 Pages |
Abstract
The transdermal bisoprolol patch was effective for a PVC reduction in patients with P-PVCs, particularly in those with faster mean HRs. Furthermore, it demonstrated a stable PVC-reducing effect during the 24-hour period in the P-PVC group.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Masaya MD, Tadashi MD, PhD, Hideki MD, Ken MD, PhD, Toshio MD, PhD, Hitomi MD, Takeya MD, PhD, Shunji MD, Kenzaburo MD, PhD, Jiro MD, PhD, Kengo MD, PhD, Takanori MD, PhD, FJCC,